» Articles » PMID: 27690369

DNA Methylation Alterations in the Pathogenesis of Lupus

Overview
Date 2016 Oct 1
PMID 27690369
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Although lupus is, by definition, associated with genetic and immunological factors, its molecular mechanisms remain unclear. The up-to-date research findings point out that various genetic and epigenetic factors, especially gene-specific and site-specific methylation, are believed to contribute to the initiation and development of systemic lupus erythematosus (SLE). This review presents and summarizes the association between abnormal DNA methylation of immune-related cells and lupus-like diseases, as well as the possible mechanisms of immune disorder caused by DNA methylation, aiming at a better understanding of the roles of aberrant DNA methylation in the initiation and development of certain forms of lupus and providing a new insight into promising therapeutic regimens in lupus-like diseases.

Citing Articles

MicroRNAs as Key Regulators in RA and SLE: Insights into Biological Functions.

Li X, Zhao C, Wei H, Li S, Tang J, Zhu Y Curr Pharm Des. 2024; 30(22):1746-1761.

PMID: 38798216 DOI: 10.2174/0113816128303695240512141729.


DNA methylation and histone post-translational modifications in atherosclerosis and a novel perspective for epigenetic therapy.

Zhang L, Xia C, Yang Y, Sun F, Zhang Y, Wang H Cell Commun Signal. 2023; 21(1):344.

PMID: 38031118 PMC: 10688481. DOI: 10.1186/s12964-023-01298-8.


MicroRNA as a potential biomarker for systemic lupus erythematosus: pathogenesis and targeted therapy.

Naithani U, Jain P, Sachan A, Khare P, Gabrani R Clin Exp Med. 2023; 23(8):4065-4077.

PMID: 37921874 DOI: 10.1007/s10238-023-01234-7.


Whole-genome bisulfite sequencing identified the key role of the Src family tyrosine kinases and related genes in systemic lupus erythematosus.

Fang T, Liu S, Chen L, Ren Y, Lu D, Yao X Genes Genomics. 2023; 45(9):1187-1196.

PMID: 37300789 DOI: 10.1007/s13258-023-01407-4.


Methylation of Promoter Is Associated with Global Hypomethylation and Hypohydroxymethylation in Peripheral Blood Mononuclear Cells of Systemic Lupus Erythematosus Patients.

Sung W, Lin Y, Hwang D, Lin C, Li R, Tseng C Diagnostics (Basel). 2022; 12(12).

PMID: 36553013 PMC: 9776498. DOI: 10.3390/diagnostics12123006.


References
1.
Dalle Vedove C, Del Giglio M, Schena D, Girolomoni G . Drug-induced lupus erythematosus. Arch Dermatol Res. 2008; 301(1):99-105. DOI: 10.1007/s00403-008-0895-5. View

2.
Harley I, Kaufman K, Langefeld C, Harley J, Kelly J . Genetic susceptibility to SLE: new insights from fine mapping and genome-wide association studies. Nat Rev Genet. 2009; 10(5):285-90. PMC: 2737697. DOI: 10.1038/nrg2571. View

3.
Dai Y, Zhang L, Hu C, Zhang Y . Genome-wide analysis of histone H3 lysine 4 trimethylation by ChIP-chip in peripheral blood mononuclear cells of systemic lupus erythematosus patients. Clin Exp Rheumatol. 2010; 28(2):158-68. View

4.
Tang Y, Luo X, Cui H, Ni X, Yuan M, Guo Y . MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum. 2009; 60(4):1065-75. DOI: 10.1002/art.24436. View

5.
Cornacchia E, Golbus J, Maybaum J, Strahler J, Hanash S, Richardson B . Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity. J Immunol. 1988; 140(7):2197-200. View